Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice
Open accessAbstract
Obesity is closely associated with the metabolic syndrome, a combination of disorders including insulin resistance, diabetes, dyslipidemia, and hypertension. A role for local glucocorticoid reamplification in obesity and the metabolic syndrome has been suggested. The enzyme 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) regenerates active cortisol from inactive 11-keto forms, and aP2-HSD1 mice with relative transgenic overexpression of this enzyme in fat cells develop visceral obesity with insulin resistance and dyslipidemia. Here we report that aP2-HSD1 mice also have high arterial blood pressure (BP). The mice have increased sensitivity to dietary salt and increased plasma levels of angiotensinogen, angiotensin II, and aldosterone. This hypertension is abolished by selective angiotensin II receptor AT-1 antagonist at a low dose that does not affect BP in non-Tg littermates. These findings suggest that activation of the circulating renin-angiotensin system (RAS) develops in aP2-HSD1 mice. The long-term hypertension is further reflected by an appreciable hypertrophy and hyperplasia of the distal tubule epithelium of the nephron, resembling salt-sensitive or angiotensin II-mediated hypertension. Taken together, our findings suggest that overexpression of 11beta-HSD1 in fat is sufficient to cause salt-sensitive hypertension mediated by an activated RAS. The potential role of adipose 11beta-HSD1 in mediating critical features of the metabolic syndrome extends beyond obesity and metabolic complications to include the most central cardiovascular feature of this disorder.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Expression of 11β-hydroxysteroid dehydrogenase in adipose tissue results in a mouse with abdominal obesity that develops hypertension.
“Expression of 11β-hydroxysteroid dehydrogenase (11β-HSD) in adipose tissue results in a mouse with abdominal obesity that develops hypertension (225).”
From Cardiac remodeling in obesity (2008) · cites this paper as [225]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481 · see citing works
Kopelman, P. G. (2000) · Nature · doi:10.1038/35007508 · Cited by 4,795 · see citing works
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,283 · see citing works
Self-citationSubcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961 · see citing works
The Concepts of Stress and Stress System Disorders: Overview of Physical and Behavioral Homeostasis
Chrousos, G. P. (1992) · JAMA · doi:10.1001/jama.1992.03480090092034 · Cited by 2,689 · see citing works
Obesity and the regulation of energy balance
Spiegelman, B. M., & Flier, J. S. (2001) · Cell · doi:10.1016/s0092-8674(01)00240-9 · Cited by 2,398 · see citing works
Self-citationA transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766 · see citing works
Self-citationO'Brien, E. T., Sheridan, J., & O'MALLEY, K. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92867-x · Cited by 1,026 · see citing works
Kotelevtsev, Y. V., Holmes, M. C., Burchell, A. N., Houston, P., Schmoll, D., Jamieson, P. M., Best, R., Brown, R., Edwards, C. R. W., Seckl, J. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14924 · Cited by 858 · see citing works
Self-citationDefinitions and characteristics of sodium sensitivity and blood pressure resistance.
Weinberger, M. H., Miller, J. Z., Luft, F. C., Grim, C. E., & Fineberg, N. S. (1986) · Hypertension · doi:10.1161/01.hyp.8.6_pt_2.ii127 · Cited by 775 · see citing works
The perils of portliness: causes and consequences of visceral adiposity.
Montague, C. T., & O’Rahilly, S. (2000) · Diabetes · doi:10.2337/diabetes.49.6.883 · Cited by 735 · see citing works
Seckl, J. R., & Walker, B. R. (2001) · Endocrinology · doi:10.1210/endo.142.4.8114 · Cited by 714 · see citing works
Self-citationTissue-Specific Dysregulation of Cortisol Metabolism in Human Obesity
Rask, E., Olsson, T., Söderberg, S., Andrew, R., Livingstone, D. E. W., Johnson, O., & Walker, B. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7453 · Cited by 657 · see citing works
Matsuzawa, Y., Funahashi, T., & Nakamura, T. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07793.x · Cited by 601 · see citing works
Björntorp, P. A., & Rosmond, R. (2000) · Nutrition · doi:10.1016/s0899-9007(00)00422-6 · Cited by 584 · see citing works
Yamamoto, H., Lee, C. E., Marcus, J. N., Williams, T. D., Overton, J., Lopez, M. E., Hollenberg, A., Baggio, L., Saper, C., Drucker, D. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15595 · Cited by 544 · see citing works
Self-citationRenal injury from angiotensin II-mediated hypertension.
Johnson, R. J., Alpers, C. E., Yoshimura, A., Lombardi, D. M., Pritzl, P., Floege, J., & Schwartz, S. M. (1992) · Hypertension · doi:10.1161/01.hyp.19.5.464 · Cited by 534 · see citing works
Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation
Massiéra, F., Bloch-Faure, M., Ceiler, D. L., Murakami, K., Fukamizu, A., Gasc, J., Quignard‐Boulangé, A., Négrel, R., Ailhaud, G. P., Seydoux, J., et al. (2001) · The FASEB Journal · doi:10.1096/fj.01-0457fje · Cited by 505 · see citing works
Pathophysiological role of leptin in obesity-related hypertension
Aizawa-Abe, M., Ogawa, Y., Masuzaki, H., Ebihara, K., Satoh, N., Iwai, H., Matsuoka, N., Hayashi, T., Hosoda, K., Inoue, G., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8341 · Cited by 477 · see citing works
Self-citationRask, E., Walker, B., Söderberg, S., Livingstone, D., Eliasson, M., Johnson, O., Andrew, R., & Olsson, T. (2002) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem.87.7.8661 · Cited by 467 · see citing works
Morton, N. M., Holmes, M. C., Fiévet, C., Staels, B., Tailleux, A., Mullins, J. J., & Seckl, J. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103676200 · Cited by 441 · see citing works
Self-citationYamamoto, H., Lee, C. E., Marcus, J. N., Williams, T. D., Overton, J. M., Lopez, M. E., Hollenberg, A. N., Baggio, L., Saper, C. B., Drucker, D. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215595 · Cited by 429 · see citing works
Self-citationLivingstone, D. E. W., Jones, G. C., Smith, K., Jamieson, P. M., Andrew, R., Kenyon, C. J., & Walker, B. R. (2000) · Endocrinology · doi:10.1210/endo.141.2.7297 · Cited by 348 · see citing works
Self-citationDiep, Q. N., Mabrouk, M. E., Cohn, J. S., Endemann, D., Amiri, F., Virdis, A., Neves, M. F., & Schiffrin, E. L. (2002) · Circulation · doi:10.1161/01.cir.0000016049.86468.23 · Cited by 345 · see citing works
Selective Angiotensin II Receptor Antagonism Reduces Insulin Resistance in Obese Zucker Rats
Henriksen, E. J., Jacob, S., Kinnick, T. R., Teachey, M. K., & Krekler, M. (2001) · Hypertension · doi:10.1161/hy1101.092970 · Cited by 293 · see citing works
Walker, W. G., Whelton, P. K., Saito, H., Russell, R. P., & Hermann, J. (1979) · Hypertension · doi:10.1161/01.hyp.1.3.287 · Cited by 292 · see citing works
Butz, G. M., & Davisson, R. L. (2001) · Physiological Genomics · doi:10.1152/physiolgenomics.2001.5.2.89 · Cited by 282 · see citing works
Hypertension in mice lacking 11β-hydroxysteroid dehydrogenase type 2
Kotelevtsev, Y. V., Brown, R. W., Fleming, S., Kenyon, C. J., Edwards, C. R. W., Seckl, J. R., & Mullins, J. J. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4445 · Cited by 278 · see citing works
Self-citationAngiotensin II–Induced Insulin Resistance Is Associated With Enhanced Insulin Signaling
Ogihara, T., Asano, T., Ando, K., Chiba, Y., Sakoda, H., Anai, M., Shojima, N., Ono, H., Onishi, Y., Fujishiro, M., et al. (2002) · Hypertension · doi:10.1161/01.hyp.0000040262.48405.a8 · Cited by 274 · see citing works
Tissue-specific nutritional regulation of angiotensinogen in adipose tissue.
Frederich, R. C., Kahn, B. B., Peach, M. J., & Flier, J. S. (1992) · Hypertension · doi:10.1161/01.hyp.19.4.339 · Cited by 244 · see citing works
Self-citationPaulmyer‐Lacroix, O., Boullu, S., Oliver, C., Alessi, M., & Grino, M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.6.8614 · Cited by 241 · see citing works
The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension
Engeli, S., & Sharma, A. M. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090000144 · Cited by 225 · see citing works
Molecular Basis of Salt Sensitivity in Human Hypertension
Poch, E., González, D., Galvañ, V. G., Bragulat, E., Coca, A., & de la Sierra, A. (2001) · Hypertension · doi:10.1161/hy1101.099479 · Cited by 202 · see citing works
Concordance of Murine Quantitative Trait Loci for Salt-Induced Hypertension with Rat and Human Loci
Sugiyama, F., Churchill, G. A., Higgins, D., Johns, C. A., Makaritsis, K. P., Gavras, H. P., & Paigen, B. J. (2001) · Genomics · doi:10.1006/geno.2000.6401 · Cited by 198 · see citing works
Pathways from obesity to hypertension: from the perspective of a vicious triangle
Montani, J.-P., Antic, V., Yang, Z., & Dulloo, A. G. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802125 · Cited by 189 · see citing works
Whorwood, C. B., Donovan, S. J., Flanagan, D., Phillips, D. I. W., & Byrne, C. D. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1066 · Cited by 184 · see citing works
Peeke, P. M., & Chrousos, G. P. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44719.x · Cited by 179 · see citing works
Increased Adipose Angiotensinogen Gene Expression in Human Obesity
van Harmelen, V., Ariapart, P., Hoffstedt, J., Lundkvist, I., Bringman, S., & Arner, P. (2000) · Obesity Research · doi:10.1038/oby.2000.40 · Cited by 172 · see citing works
Seckl, J. R. (2001) · Endocrinology · doi:10.1210/en.142.4.1371 · Cited by 172 · see citing works
Self-citationLlorens‐Cortés, C., Greenberg, B., Huang, H., & Corvol, P. L. (1994) · Hypertension · doi:10.1161/01.hyp.24.5.538 · Cited by 168 · see citing works
Bassett, M., Zhang, Y., Clyne, C., White, P., & Rainey, W. (2002) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0280125 · Cited by 146 · see citing works
A Mouse Model for Liddle's Syndrome
Pradervand, S., Wang, Q., Burnier, M., Beermann, F., Horisberger, J. D., Hümmler, E., & Rossier, B. C. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v10122527 · Cited by 144 · see citing works
Crosstalk between insulin and angiotensin II signalling systems
Folli, F. B., Saad, M. J. A., Velloso, L. A., Hansen, H. F., Carandente, O., Feener, E. P., & Kahn, C. R. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1212088 · Cited by 139 · see citing works
Cardiovascular responses to caloric restriction and thermoneutrality in C57BL/6J mice
Williams, T. D., Chambers, J. B., Henderson, R. P., Rashotte, M. E., & Overton, J. M. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00612.2001 · Cited by 132 · see citing works
Rask, E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3330 · Cited by 127 · see citing works
Livingstone, D. E. W. (2000) · Endocrinology · doi:10.1210/en.141.2.560 · Cited by 121 · see citing works
Pathophysiology of modulation of local glucocorticoid levels by 11β-hydroxysteroid dehydrogenases
Sandeep, T. C., & Walker, B. R. (2001) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(01)00499-4 · Cited by 120 · see citing works
Augmented adrenergic vasoconstriction in hypertensive diabetic obese Zucker rats
Stepp, D. W., & Frisbee, J. C. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00695.2001 · Cited by 118 · see citing works
van Harmelen, V, Elizalde, M., Ariapart, P., Bergstedt-Lindqvist, S., Reynisdottir, S., Hoffstedt, J., Lundkvist, I., Bringman, S., & Arner, P. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801217 · Cited by 114 · see citing works
Regulation by glucocorticoids of angiotensinogen gene expression and secretion in adipose cells
Aubert, J., Darimont, C., SAFONOVA, I., Ailhaud, G. P., & Négrel, R. (1997) · Biochemical Journal · doi:10.1042/bj3280701 · Cited by 96 · see citing works
Rotimi, C. N., Cooper, R., Ogunbiyi, O. J., Morrison, L. C., Ladipo, M. M., Tewksbury, D. A., & Ward, R. H. (1997) · Circulation · doi:10.1161/01.cir.95.10.2348 · Cited by 93 · see citing works
Hypertension in CB57BL/6J mouse model of non-insulin-dependent diabetes mellitus
Mills, E., Kuhn, C. M., Feinglos, M. N., & Surwit, R. S. (1993) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1993.264.1.r73 · Cited by 89 · see citing works
FAMILIAL RESEMBLANCE IN THE BLOOD PRESSURE RESPONSE TO SODIUM RESTRICTION
Miller, J. Z., Weinberger, M. H., Christian, J. C., & Daugherty, S. A. (1987) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114719 · Cited by 89 · see citing works
Mechanisms of dysregulation of 11 beta-hydroxysteroid dehydrogenase type 1 in obese Zucker rats
Livingstone, D., Kenyon, C., & Walker, B. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1670533 · Cited by 88 · see citing works
Self-citationTomlinson, J., Draper, N., Mackie, J., Johnson, A. P., Holder, G., Wood, P. J., & Stewart, P. M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.1.8189 · Cited by 81 · see citing works
Hadoke, P. W. F., Christy, C., Kotelevtsev, Y. V., Williams, B. C., Kenyon, C. J., Seckl, J. R., Mullins, J. J., & Walker, B. R. (2001) · Circulation · doi:10.1161/hc4801.100077 · Cited by 79 · see citing works
Self-citationMorton, J. J., & Wallace, E. C. H. (1983) · Clinical Science · doi:10.1042/cs0640359 · Cited by 78 · see citing works
Visceral obesity and the metabolic syndrome: effects of weight loss.
Busetto, L. (2001) · PubMed · Cited by 76 · see citing works
Genetic and nongenetic determinants of salt sensitivity and blood pressure
Aw, C. (1997) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.2.587s · Cited by 72 · see citing works
ANGIOTENSIN RECEPTORS: MOLECULAR BIOLOGY AND SIGNALLING
Inagami, T., Kambayashi, Y., Ichiki, T., Tsuzuki, S., Eguchi, S., & Yamakawa, T. (1999) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.1999.03086.x · Cited by 72 · see citing works
Paulmyer-Lacroix, O. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.6.2701 · Cited by 72 · see citing works
Angiotensinogen in Essential Hypertension
Lalouel, J.-M., Rohrwasser, A., Terreros, D. A., Morgan, T. K., & Ward, K. J. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v123606 · Cited by 64 · see citing works
de la Sierra, A., Lluch, M. D. M., Coca, A., Aguilera, M. T., Galvañ, V. G., Bragulat, E., & Urbano-Márquez, A. (1996) · Clinical Science · doi:10.1042/cs0910155 · Cited by 58 · see citing works
Skeletal Muscle Glucocorticoid Receptor Density and Insulin Resistance
Reynolds, R. M., Chapman, K. E., Seckl, J. R., Walker, B. R., McKeigue, P., & Lithell, H. O. (2002) · JAMA · doi:10.1001/jama.287.19.2505 · Cited by 56 · see citing works
Self-citationEarly morning surge in blood pressure
Shimada, K., Kario, K., Umeda, Y., Hoshide, S., Hoshide, Y., & Eguchi, K. (2001) · Blood Pressure Monitoring · doi:10.1097/00126097-200112000-00015 · Cited by 53 · see citing works
Uncontrolled early morning blood pressure in medicated patients: the ACAMPA study
Redón, J., Roca‐Cusachs, À., & Mora‐Macía, J. (2002) · Blood Pressure Monitoring · doi:10.1097/00126097-200204000-00004 · Cited by 53 · see citing works
Emerging concepts in the pathophysiology and treatment of obesity-associated hypertension
Engeli, S., & Sharma, A. M. (2002) · Current Opinion in Cardiology · doi:10.1097/00001573-200207000-00006 · Cited by 50 · see citing works
Angiotensinogen, adipocyte differentiation and fat mass enlargement
Ailhaud, G. P., Teboul, M., & Massiéra, F. (2002) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200207000-00006 · Cited by 44 · see citing works
Regulation of Very-Low-Density Lipoprotein Receptor in Hypertrophic Rat Heart
Masuzaki, H., Jingami, H., Matsuoka, N., Nakagawa, O., Ogawa, Y., Mizuno, M., Yoshimasa, Y., Yamamoto, T. T., & Nakao, K. (1996) · Circulation Research · doi:10.1161/01.res.78.1.8 · Cited by 43 · see citing works
Self-citationKatovich, M. J., Reaves, P. Y., Francis, S., Pachori, A. S., Wang, H., & Raizada, M. K. (2001) · Journal of Hypertension · doi:10.1097/00004872-200109000-00006 · Cited by 42 · see citing works
Dietary obesity and weight cycling: effects on blood pressure and heart rate in rats
Contreras, R. J., & Williams, V. L. (1989) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1989.256.6.r1209 · Cited by 35 · see citing works
Hodge, G., Ye, V. Z. C., & Duggan, K. A. (2002) · Experimental Physiology · doi:10.1113/eph8702322 · Cited by 28 · see citing works
Velliquette, R. A., Koletsky, R. J., & Ernsberger, P. R. (2002) · Experimental Biology and Medicine · doi:10.1177/153537020222700303 · Cited by 25 · see citing works
Ebisu, H., Nishikawa, M., Tanaka, M., Okazoe, T., Morizawa, Y., Shinyama, H., & Nakamura, N. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199910000-00008 · Cited by 24 · see citing works
Self-citationVisceral Obesity and the Metabolic Syndrome
Rosmond, R. (2001) · Wiley eBooks · doi:10.1002/0470846739.ch23 · Cited by 21 · see citing works
Pratt, J. H., Ambrosius, W. T., Tewksbury, D. A., Wagner, M. A., Zhou, L., & Hanna, M. P. (1998) · Hypertension · doi:10.1161/01.hyp.32.5.875 · Cited by 18 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522 · see citing works
Self-citationHolland, W. L., Brozinick, J. T., Wang, L.-P., Hawkins, E. D., Sargent, K. M., Liu, Y., Narra, K., Hoehn, K. L., Knotts, T. A., Siesky, A., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.01.002 · Cited by 1,232 · see citing works
11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response
Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., Hewison, M., & Stewart, P. M. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0031 · Cited by 969 · see citing works
Seravalle, G., & Grassi, G. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.013 · Cited by 909 · see citing works
11β-hydroxysteroid dehydrogenases: Intracellular gate-keepers of tissue glucocorticoid action
Chapman, K., Holmes, M., & Seckl, J. (2013) · Physiological Reviews · doi:10.1152/physrev.00020.2012 · Cited by 887 · see citing works
Self-citationObesity-Associated Hypertension
Rahmouni, K., Correia, M., Haynes, W. G., & Mark, A. L. (2004) · Hypertension · doi:10.1161/01.hyp.0000151325.83008.b4 · Cited by 784 · see citing works
Abel, E. D., Litwin, S. E., & Sweeney, G. (2008) · Physiological Reviews · doi:10.1152/physrev.00017.2007 · Cited by 736 · see citing works
Kuo, L. E., Kitlinska, J. B., Tilan, J. U., Li, L., Baker, S. B., Johnson, M. D., Lee, E. W., Burnett, M. S., Fricke, S. T., Kvetnansky, R., et al. (2007) · Nature Medicine · doi:10.1038/nm1611 · Cited by 656 · see citing works
Adipose Tissue as an Endocrine Organ
Ahima, R. S. (2006) · Obesity · doi:10.1038/oby.2006.317 · Cited by 636 · see citing works
Mechanisms of obesity-induced hypertension
Kotsis, V., Stabouli, S., Papakatsika, S., Rizos, Z., & Parati, G. (2010) · Hypertension Research · doi:10.1038/hr.2010.9 · Cited by 632 · see citing works
Metabolic Syndrome: A Clinical and Molecular Perspective
Moller, D. E., & Kaufman, K. D. (2004) · Annual Review of Medicine · doi:10.1146/annurev.med.56.082103.104751 · Cited by 631 · see citing works
Weight Loss and the Renin-Angiotensin-Aldosterone System
Engeli, S., Böhnke, J., Gorzelniak, K., Janke, J., Schling, P., Bäder, M., Luft, F. C., & Sharma, A. M. (2005) · Hypertension · doi:10.1161/01.hyp.0000154361.47683.d3 · Cited by 625 · see citing works
The Pathogenetic Role of Cortisol in the Metabolic Syndrome: A Hypothesis
Anagnostis, P. G., Athyros, V. G., Τζιόμαλος, Κ., Karagiannis, A. I., & Mikhailidis, D. P. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0370 · Cited by 613 · see citing works
Holland, W. L., & Summers, S. A. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0025 · Cited by 594 · see citing works
Glucocorticoids, metabolism and metabolic diseases
Vegiopoulos, A., & Herzig, S. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.05.015 · Cited by 535 · see citing works
Morton, N. M., Paterson, J. M., Masuzaki, H., Holmes, M. C., Staels, B., Fievet, C., Walker, B. R., Flier, J. S., Mullins, J. J., & Seckl, J. R. (2004) · Diabetes · doi:10.2337/diabetes.53.4.931 · Cited by 512 · see citing works
Self-citationMathieu, P., Poirier, P., Pîbarot, P., Lemieux, I., & Després, J. (2009) · Hypertension · doi:10.1161/hypertensionaha.108.110320 · Cited by 489 · see citing works
Glucocorticoid regulation of the circadian clock modulates glucose homeostasis
So, A. Y.-L., Bernal, T. U., Pillsbury, M. L., Yamamoto, K. R., & Feldman, B. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909733106 · Cited by 431 · see citing works
Paterson, J. M., Morton, N. M., Fiévet, C., Kenyon, C. J., Holmes, M. C., Staels, B., Seckl, J. R., & Mullins, J. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305524101 · Cited by 427 · see citing works
Self-citationObesity-Related Hypertension: Epidemiology, Pathophysiology, and Clinical Management
Kotchen, T. A. (2010) · American Journal of Hypertension · doi:10.1038/ajh.2010.172 · Cited by 412 · see citing works
Mechanisms of Glucocorticoid-Induced Insulin Resistance
Geer, E. B., Islam, J., & Buettner, C. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.10.005 · Cited by 392 · see citing works
Macfarlane, D. P., Forbes, S., & Walker, B. R. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0054 · Cited by 385 · see citing works
Hermanowski‐Vosatka, A., Balkovec, J. M., Cheng, K., Chen, H. Y., Hernandez, M., Koo, G. C., LeGrand, C. B., Li, Z., Metzger, J. M., Mundt, S. S., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050119 · Cited by 361 · see citing works
Dairy augmentation of total and central fat loss in obese subjects
Zemel, M. B., Richards, J., Mathis, S., Milstead, A., Gebhardt, L., & Silva, E. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802880 · Cited by 356 · see citing works
Rosenstock, J., Banarer, S., Fonseca, V. A., Inzucchi, S. E., Sun, W. Y., Yao, W., Hollis, G. F., Flores, R., Levy, R., Williams, W. V., et al. (2010) · Diabetes Care · doi:10.2337/dc09-2315 · Cited by 315 · see citing works
Self-citationEffects of Calcium and Dairy on Body Composition and Weight Loss in African‐American Adults
Zemel, M. B., Richards, J., Milstead, A., & Campbell, P. T. (2005) · Obesity Research · doi:10.1038/oby.2005.144 · Cited by 314 · see citing works
Glucocorticoid sensitivity in health and disease
Quax, R. A., Manenschijn, L., Koper, J. W., Hazes, J. M., Lamberts, S. W. J., van Rossum, E. F. C., & Feelders, R. A. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.183 · Cited by 310 · see citing works
Grün, F., & Blumberg, B. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9049-x · Cited by 307 · see citing works
The role of glucocorticoid action in the pathophysiology of the Metabolic Syndrome
Wang, M. (2005) · Nutrition & Metabolism · doi:10.1186/1743-7075-2-3 · Cited by 276 · see citing works
11β-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess
Morgan, S., McCabe, E. L., Gathercole, L., Hassan-Smith, Z. K., Larner, D. P., Bujalska, I. J., Stewart, P. M., Tomlinson, J., & Lavery, G. G. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323681111 · Cited by 273 · see citing works
The Role of Dairy Foods in Weight Management
Zemel, M. B. (2005) · Journal of the American College of Nutrition · doi:10.1080/07315724.2005.10719502 · Cited by 273 · see citing works
Obesity-Initiated Metabolic Syndrome and the Kidney
Bagby, S. P. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000141965.28037.ee · Cited by 253 · see citing works
Adipocyte-Specific Glucocorticoid Inactivation Protects Against Diet-Induced Obesity
Kershaw, E. E., Morton, N. M., Dhillon, H., Ramage, L. E., Seckl, J. R., & Flier, J. S. (2005) · Diabetes · doi:10.2337/diabetes.54.4.1023 · Cited by 253 · see citing works
Self-citationGlucocorticoids and 11beta-Hydroxysteroid Dehydrogenase in Adipose Tissue
Seckl, J. R. (2004) · Recent Progress in Hormone Research · doi:10.1210/rp.59.1.359 · Cited by 239 · see citing works
“The hypertension is associated with renin-angiotensin-aldosterone system (RAAS) activation and is strikingly sensitive to low doses of an angiotensin II receptor antagonist (Masuzaki et al., 2003).”
Self-citationRegulation of 11β‐HSD Genes in Human Adipose Tissue: Influence of Central Obesity and Weight Loss
Engeli, S., Böhnke, J., Feldpausch, M., Gorzelniak, K., Heintze, U., Janke, J., Luft, F. C., & Sharma, A. M. (2004) · Obesity Research · doi:10.1038/oby.2004.3 · Cited by 211 · see citing works
Kaserer, T., Beck, K. R., Akram, M., Odermatt, A., & Schuster, D. (2015) · Molecules · doi:10.3390/molecules201219880 · Cited by 208 · see citing works
Lavery, G. G., Walker, E. A., Draper, N., Jeyasuria, P., Marcos, J., Shackleton, C. H. L., Parker, K. L., White, P. C., & Stewart, P. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512635200 · Cited by 207 · see citing works
Sandeep, T. C., Andrew, R., Homer, N. Z. M., Andrews, R. C., Smith, K., & Walker, B. R. (2005) · Diabetes · doi:10.2337/diabetes.54.3.872 · Cited by 205 · see citing works
11β-hydroxysteroid dehydrogenase 1: translational and therapeutic aspects
Gathercole, L. L., Lavery, G. G., Morgan, S. A., Cooper, M. S., Sinclair, A. J., Tomlinson, J. W., & Stewart, P. M. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1050 · Cited by 196 · see citing works
The renin angiotensin system and the metabolic syndrome
de Kloet, A. D., Krause, E. G., & Woods, S. C. (2010) · Physiology & Behavior · doi:10.1016/j.physbeh.2010.03.018 · Cited by 194 · see citing works
Boullu‐Ciocca, S., Dutour, A., Guillaume, V., Achard, V., Oliver, C., & Grino, M. (2005) · Diabetes · doi:10.2337/diabetes.54.1.197 · Cited by 188 · see citing works
11β-hydroxysteroid dehydrogenases: changing glucocorticoid action
Seckl, J. R. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.09.001 · Cited by 185 · see citing works
Self-citationAdipose tissue as an active endocrine organ: recent advances
Gimeno, R. E., & Klaman, L. D. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.01.006 · Cited by 180 · see citing works
Yu, C.-Y., Mayba, O., Lee, J. V., Tran, J., Harris, C. L., Speed, T. P., & Wang, J.-C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015188 · Cited by 179 · see citing works
Cortisol—cause and cure for metabolic syndrome?
Walker, B. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01998.x · Cited by 179 · see citing works
Bánhegyi, G., Benedetti, A., Fulceri, R., & Senesi, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404159200 · Cited by 169 · see citing works
Glucocorticoids and Type 2 Diabetes: From Physiology to Pathology
Di Dalmazi, G., Pagotto, U., Pasquali, R., & Vicennati, V. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/525093 · Cited by 168 · see citing works
Morton, N. M. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.09.024 · Cited by 163 · see citing works
Self-citationInhibition of 11ß-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target
Wamil, M., & Seckl, J. R. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.06.001 · Cited by 162 · see citing works
Self-citationValsamakis, G., Anwar, A., Tomlinson, J., Shackleton, C. H. L., McTernan, P. G., Chetty, R., Wood, P. J., Banerjee, A. K., Holder, G., Barnett, A. H., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032240 · Cited by 160 · see citing works
Diabetes and its comorbidities—where East meets West
Kong, A. P. S., Xu, G., Brown, N., So, W., Ronald, C. W., & Chan, J. C. N. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.102 · Cited by 159 · see citing works
The renin–angiotensin system in adipose tissue and its metabolic consequences during obesity
Frigolet, M. E., Torres, N., & Tovar, A. R. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.07.002 · Cited by 156 · see citing works
Brain Adipocytokine Action and Metabolic Regulation
Ahima, R. S., Qi, Y., Singhal, N. S., Jackson, M. B., & Scherer, P. E. (2006) · Diabetes · doi:10.2337/db06-s018 · Cited by 150 · see citing works
Tissue Production of Cortisol by 11β‐Hydroxysteroid Dehydrogenase Type 1 and Metabolic Disease
Walker, B. R., & Andrew, R. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1367.012 · Cited by 148 · see citing works
Adipose tissue as a secretory organ: from adipogenesis to the metabolic syndrome
Ailhaud, G. P. (2006) · Comptes Rendus Biologies · doi:10.1016/j.crvi.2005.12.012 · Cited by 142 · see citing works
Glucocorticoid-mediated mineralocorticoid receptor activation and hypertension
Frey, F. J., Odermatt, A., & Frey, B. M. (2004) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000133976.32559.b0 · Cited by 135 · see citing works
11β‐HSD Type 1 Expression in Human Adipose Tissue: Impact of Gender, Obesity, and Fat Localization
Paulsen, S. K., Pedersen, S. B., Fisker, S., & Richelsen, B. (2007) · Obesity · doi:10.1038/oby.2007.233 · Cited by 136 · see citing works
11&Bgr;-Hydroxysteroid Dehydrogenase Type 1 and Obesity
Morton, N. M., & Seckl, J. R. (2008) · KARGER eBooks · doi:10.1159/000115363 · Cited by 134 · see citing works
Self-citationSeckl, J. R., & Walker, B. R. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.09.007 · Cited by 134 · see citing works
Self-citationFrom big fat cells to high blood pressure: a pathway to obesity-associated hypertension
Pausová, Z. (2006) · Current Opinion in Nephrology & Hypertension · doi:10.1097/01.mnh.0000214775.42103.a5 · Cited by 133 · see citing works
Rapid Hepatic Metabolism of 7-Ketocholesterol by 11β-Hydroxysteroid Dehydrogenase Type 1
Schweizer, R. A. S., Zürcher, M., Balázs, Z., Dick, B., & Odermatt, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313615200 · Cited by 131 · see citing works
DiNicolantonio, J. J., Mehta, V., Onkaramurthy, N. J., & O’Keefe, J. H. (2017) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2017.12.001 · Cited by 132 · see citing works
Obesity-hypertension: an ongoing pandemic
Francischetti, E. A., & Genelhu, V. A. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01262.x · Cited by 130 · see citing works
Kurukulasuriya, L. R., Stas, S. N., Lastra, G., Manrique, C. M., & Sowers, J. R. (2011) · Medical Clinics of North America · doi:10.1016/j.mcna.2011.06.004 · Cited by 127 · see citing works
Hoppmann, J., Perwitz, N., Meier, B., Faßhauer, M., Hadaschik, D., Lehnert, H., & Klein, J. C. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0292 · Cited by 122 · see citing works
Role of glucocorticoids in the physiopathology of excessive fat deposition and insulin resistance
Asensio, C. S., Muzzin, P., & Rohner‐Jeanrenaud, F. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802856 · Cited by 122 · see citing works
Velkoska, E., Cole, T. J., & Morris, M. J. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00505.2004 · Cited by 122 · see citing works
Adipose depot-specific modulation of angiotensinogen gene expression in diet-induced obesity
Rahmouni, K., Mark, A. L., Haynes, W. G., & Sigmund, C. D. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00551.2003 · Cited by 121 · see citing works
Chapman, K. E., Coutinho, A. E., Zhang, Z., Kipari, T. M. J., Savill, J., & Seckl, J. R. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.02.002 · Cited by 118 · see citing works
Self-citationMetabolic Syndrome in Cushing’s Syndrome
Chanson, P., & Salenave, S. (2010) · Neuroendocrinology · doi:10.1159/000314272 · Cited by 118 · see citing works
Pereira, C., Azevedo, I., Monteiro, R., & Martins, M. J. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01582.x · Cited by 113 · see citing works
11β-Hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome
Wake, D. J., & Walker, B. R. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.11.015 · Cited by 111 · see citing works
Morton, N. M., Ramage, L. E., & Seckl, J. R. (2004) · Endocrinology · doi:10.1210/en.2003-1674 · Cited by 111 · see citing works
Self-citationSchuster, D., Maurer, E. M., Laggner, C., Nashev, L. G., Wilckens, T., Langer, T., & Odermatt, A. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0600794 · Cited by 110 · see citing works
Renin receptor expression in human adipose tissue
Achard, V., Boullu‐Ciocca, S., Desbrière, R., Nguyen, G., & Grino, M. (2006) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00439.2005 · Cited by 109 · see citing works
Anagnostis, P. G., Katsiki, N., Adamidou, F., Athyros, V. G., Karagiannis, A. I., Kita, M. D., & Mikhailidis, D. P. (2012) · Metabolism · doi:10.1016/j.metabol.2012.05.002 · Cited by 107 · see citing works
Hypertension, Kidney, and Transgenics: A Fresh Perspective
Mullins, L. J., Bailey, M. A., & Mullins, J. J. (2006) · Physiological Reviews · doi:10.1152/physrev.00016.2005 · Cited by 103 · see citing works
Self-citationHolmes, M. C., Carter, R. N., Noble, J., Chitnis, S., Dutia, A., Paterson, J. M., Mullins, J. J., Seckl, J. R., & Yau, J. L. W. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0731-10.2010 · Cited by 103 · see citing works
Self-citationBays, H., Blonde, L., & Rosenson, R. (2006) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.4.6.871 · Cited by 111 · see citing works
Omental 11β‐hydroxysteroid Dehydrogenase 1 Correlates with Fat Cell Size Independently of Obesity
Michailidou, Z., Jensen, M. D., Dumesic, D. A., Chapman, K. E., Seckl, J. R., Walker, B. R., & Morton, N. M. (2007) · Obesity · doi:10.1038/oby.2007.618 · Cited by 102 · see citing works
Self-citationCorticosteroid receptors, macrophages and cardiovascular disease
Rickard, A. J., & Young, M. J. (2009) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0144 · Cited by 101 · see citing works
Fujimoto, M., Masuzaki, H., Tanaka, T., Yasue, S., Tomita, T., Okazawa, K., Fujikura, J., Chusho, H., Ebihara, K., Hayashi, T., et al. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.09.027 · Cited by 100 · see citing works
Self-citationTherapeutic manipulation of glucocorticoid metabolism in cardiovascular disease
Hadoke, P. W. F., Iqbal, J., & Walker, B. R. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00047.x · Cited by 98 · see citing works
The Contribution of Visceral Adipose Tissue to Splanchnic Cortisol Production in Healthy Humans
Andrew, R., Westerbacka, J., Wahren, J., Yki‐Järvinen, H., & Walker, B. R. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1364 · Cited by 98 · see citing works
Tomlinson, J., Sherlock, M., Hughes, B., Hughes, S. V., Kilvington, F., Bartlett, W. A., Courtney, R., Rejto, P. A., Carley, W. W., & Stewart, P. M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2325 · Cited by 98 · see citing works
Adipose tissue renin–angiotensin–aldosterone system (RAAS) and progression of insulin resistance
Marcus, Y., Shefer, G., & Stern, N. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.06.021 · Cited by 93 · see citing works
Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue
Apostolova, G., Schweizer, R. A. S., Balázs, Z., Kostadinova, R. M., & Odermatt, A. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00442.2004 · Cited by 87 · see citing works
Mount, D. B., Kwon, C. Y., & Zandi‐Nejad, K. (2006) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2006.02.006 · Cited by 89 · see citing works
Hirata, A., Maeda, N., Nakatsuji, H., Hiuge-Shimizu, A., Okada, T., Funahashi, T., & Shimomura, I. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.01.139 · Cited by 88 · see citing works
A novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesis
Bujalska, I. J., Gathercole, L., Tomlinson, J., Darimont, C., Ermolieff, J., Fanjul, A. N., Rejto, P. A., & Stewart, P. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0050 · Cited by 85 · see citing works
11β-HSD1 Inhibitors for the Treatment of Type 2 Diabetes and Cardiovascular Disease
Anderson, A., & Walker, B. R. (2013) · Drugs · doi:10.1007/s40265-013-0112-5 · Cited by 79 · see citing works
Véniant, M. M., Hale, C., Hungate, R. W., Gahm, K. H., Emery, M. G., Jona, J. A., Joseph, S., Adams, J., Hague, A. B., Moniz, G. A., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100242d · Cited by 82 · see citing works
Targeting the pre-receptor metabolism of cortisol as a novel therapy in obesity and diabetes
Gathercole, L., & Stewart, P. M. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.03.060 · Cited by 82 · see citing works
Mineralocorticoid receptors in the metabolic syndrome
Zennaro, M., Caprio, M., & Fève, B. (2009) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2009.05.006 · Cited by 79 · see citing works
Tarantino, G. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i40.6735 · Cited by 81 · see citing works
1, 25‐Dihydroxyvitamin D3 Modulation of Adipocyte Glucocorticoid Function
Morris, K. L., & Zemel, M. B. (2005) · Obesity Research · doi:10.1038/oby.2005.75 · Cited by 81 · see citing works
Girard, J. R., & Lafontan, M. (2008) · Diabetes & Metabolism · doi:10.1016/j.diabet.2008.04.002 · Cited by 80 · see citing works
Rohde, J. J., Pliushchev, M. A., Sorensen, B. K., Wódka, D., Shuai, Q., Wang, J., Fung, S., Monzon, K., Chiou, W. J. H., Pan, L., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0609364 · Cited by 78 · see citing works
Uncoupled Redox Systems in the Lumen of the Endoplasmic Reticulum
Piccirella, S., Czegle, I., Lizák, B., Margittai, É., Senesi, S., Papp, E., Csala, M., Fulceri, R., Csermely, P., Mandl, J., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m509406200 · Cited by 78 · see citing works
Veilleux, A., Rhéaume, C., Daris, M., Luu-The, V., & Tchernof, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2011 · Cited by 77 · see citing works
- Authors
- Masuzaki, H., Yamamoto, H., Kenyon, C. J., Elmquist, J. K., Morton, N. M., Paterson, J. M., Shinyama, H., Sharp, M. G. F., Fleming, S., Mullins, J. J., Seckl, J. R., & Flier, J. S.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- University of Edinburgh (GB)
- University of Dundee (GB)
- Corresponding author
- Flier, Jeffrey S.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2003-07-01
- Volume
- 112
- Issue
- 1
- Pages
- 83-90
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC162290
- OpenAlex
- W2127764698
- Cited by
- 434
- References
- 76
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 5 · 2023: 6 · 2022: 5 · 2021: 5 · 2020: 3 · 2019: 10 · 2018: 4 · 2017: 20 · 2016: 17 · 2015: 20 · 2014: 16 · 2013: 30 · 2012: 21
- FWCI
- 26.13
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion, other-oa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Eli Lilly and Company
- Wellcome Trust
- National Institutes of Health (5r01dk059751-02)
- National Institute of Diabetes and Digestive and Kidney Diseases (P01DK056116, DK56116, DK 59751)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- 11β-hydroxysteroid dehydrogenase type 1, adipose tissue, hypertension, salt-sensitive hypertension, renin-angiotensin system, angiotensin II, aldosterone, metabolic syndrome, obesity, transgenic mice
- MeSH terms
- Adipose Tissue, Animals, Glucocorticoids, Hydroxysteroid Dehydrogenases, Hypertension, Kidney, Male, Mice, Transgenic, Renin-Angiotensin System, Sodium Chloride, 11-beta-Hydroxysteroid Dehydrogenases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
